Brief: Ryvu Therapeutics Q1 Net Loss Narrows To 17.6 Mln Zlotys
16/05/2023 16:09
May 16 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q1 NET LOSS 17.6 MILLION ZLOTYS VERSUS LOSS OF 26.5
MILLION
ZLOTYS YEAR AGO
* Q1 OPERATING REVENUE 18.3 MILLION ZLOTYS VERSUS 6.8
MILLION
ZLOTYS YEAR AGO
* Q1 OPERATING LOSS 18.1 MILLION ZLOTYS VERSUS LOSS OF 26.8
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM76qdwMa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project